Mineralocorticoid receptor antagonists use in patients with heart failure and impaired renal function.
<h4>Aims</h4>Impaired renal function is a major contributor to the low proportion of mineralocorticoid receptor antagonist (MRA) treatment in patients with heart failure with reduced ejection fraction (HFrEF). Our aims were to investigate the impact of MRA treatment on all-cause mortalit...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Public Library of Science (PLoS)
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/87f3747ff87c4b64a863204fda7adadc |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|